Related Experiment Video
Updated: Feb 3, 2026

Measuring Bone Remodeling and Recreating the Tumor-Bone Microenvironment Using Calvaria Co-culture and Histomorphometry
Published on: March 14, 2020
Potentiating Chemo-Immunotherapy via a Programmable Nanocapsule-Hydrogel Platform for Sequential Tumor
Xiaoyan Qin1,2, Yushu Wang3, Yunhao Feng1
1State Key Laboratory of Organic-Inorganic Composites, Beijing University of Chemical Technology, Beijing, China.
This study introduces a novel silk hydrogel platform for cancer treatment, combining chemotherapy and immunotherapy for sustained antitumor responses. The programmable delivery system enhances immune cell activity and persistence within the tumor microenvironment.
Area of Science:
- Biomedical Engineering
- Cancer Research
- Immunotherapy
Background:
- Durable cancer immunotherapy responses depend on strong antitumor immunity and sustained immune pressure within the immunosuppressive tumor microenvironment (TME).
- Conventional chemotherapy combined with immunotherapy faces challenges like unpredictable response durations and systemic toxicity.
Purpose of the Study:
- To develop a programmable delivery platform integrating chemotherapy and immune checkpoint blockade for enhanced cancer treatment.
- To overcome the limitations of current chemo-immunotherapy combinations by controlling drug release kinetics at tumor sites.
Main Methods:
- A silk fibroin hydrogel platform with pH-responsive nanocapsules was engineered for controlled, spatiotemporal release of oxaliplatin (chemotherapy) and anti-PD-L1 (immunotherapy).
- Leveraged molecular weight differences for differential release: rapid diffusion of oxaliplatin and gradual degradation of anti-PD-L1 nanocapsules within the TME.
- Evaluated the platform's efficacy in a murine breast tumor model, assessing tumor cell immunogenicity, TME modulation, antitumor responses, and T cell memory.
Main Results:
- The platform successfully initiated tumor-intrinsic immunogenic stress via oxaliplatin release.
- Sustained engagement of immune checkpoints was achieved through gradual release of anti-PD-L1 from nanocapsules.
- The combined approach converted non-immunogenic tumor cells into an immunogenic state, modulated the TME, and promoted durable antitumor responses.
- Long-term central memory T cell persistence was observed in the treated murine model.
Conclusions:
- This multifunctional silk hydrogel platform offers a generalizable strategy for next-generation chemo-immunotherapy combinations.
- Controlled temporal release of chemotherapy and immunotherapy can overcome limitations of current treatments and improve durable antitumor immunity.
Related Concept Videos
Tumor Immunotherapy
The Tumor Microenvironment
Nucleosome Remodeling
Nucleosome remodeling complex
Eukaryotic cells have specialized enzymes called ATP-dependent nucleosome remodeling enzymes. These enzymes...
Bone Remodeling
Osteoclasts in Bone Remodeling
Potential Energy
Chemical bonds that form attractive forces between atoms also contain potential energy, called chemical energy. When a chemical reaction...

